Patient‐Derived Upper Tract Urothelial Carcinoma Organoids as a Platform for Drug Screening-Reference-Cited by-同舟云学术

Patient‐Derived Upper Tract Urothelial Carcinoma Organoids as a Platform for Drug Screening

Published:2021-12-16 Issue:4 Volume:9 Page:2103999
ISSN:2198-3844
Container-title:Advanced Science
language:en
Short-container-title:Advanced Science

Author:

Li Zhichao¹²^ORCID,Xu Haibo²,Gong Yanqing¹,Chen Wei²³,Zhan Yonghao¹,Yu Lei³⁴,Sun Yangyang³⁴,Li Aolin¹,He Shiming¹,Guan Bao¹,Wu Yucai¹,Xiong Gengyan¹,Fang Dong¹,He Yuhui¹,Tang Qi¹,Yao Lin¹,Hu Zheng⁴,Mei Hongbing²³,He Zhisong¹,Cai Zhiming²³⁴,Guo Yinglu¹,Li Xuesong¹,Zhou Liqun¹,Huang Weiren¹²³⁴

Affiliation:

1. Department of Urology Peking University First Hospital National Urological Cancer Center Beijing 100034 China

2. Department of Urology Shenzhen Institute of Translational Medicine Shenzhen Second People's Hospital The First Affiliated Hospital of Shenzhen University International Cancer Center of Shenzhen University Shenzhen 518039 China

3. Guangdong Key Laboratory of Systems Biology and Synthetic Biology for Urogenital Tumors Shenzhen 518035 China

4. Shenzhen Institute of Synthetic Biology Shenzhen Institutes of Advanced Technology Chinese Academy of Sciences Shenzhen 518055 China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

General Physics and Astronomy,General Engineering,Biochemistry, Genetics and Molecular Biology (miscellaneous),General Materials Science,General Chemical Engineering,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/advs.202103999

Reference72 articles.

1. Cancer statistics, 2019

2. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update

3. Outcomes of radical nephroureterectomy: A series from the Upper Tract Urothelial Carcinoma Collaboration

4. Prognostic Factors in Upper Urinary Tract Urothelial Carcinomas: A Comprehensive Review of the Current Literature

5. Upper tract urothelial carcinoma: a different disease entity in terms of management

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineered targeting OIP5 sensitizes bladder cancer to chemotherapy resistance via TRIP12-PPP1CB-YBX1 axis;Oncogene;2024-08-18

2. Establishment of bladder cancer spheroids and cultured in microfluidic platform for predicting drug response;Bioengineering & Translational Medicine;2023-12-04

3. Use and application of organ-on-a-chip platforms in cancer research;Journal of Cell Communication and Signaling;2023-11-30

4. Effects of Scaffolds on Urine- and Urothelial Carcinoma Tissue-Derived Organoids from Bladder Cancer Patients;Cells;2023-08-20

5. Effective Treatment for Recurrent Ovarian Cancer Guided by Drug Sensitivity from Ascites-Derived Organoid: A Case Report;International Journal of Women's Health;2023-07